Raz Malik

Raz Malik is an accomplished leader in pharmaceutical marketing and commercialization, currently serving as the Global Commercial Lead for Mezagitamab at Takeda Pharmaceuticals since June 2025, where the focus is on the global strategy for IgA Nephropathy. Prior experience includes a role as AD Cross Functional Launch Lead & Senior Director of Marketing at Dermavant Sciences, where significant contributions were made to the launch of VTAMA in Atopic Dermatitis, and previous positions at Sanofi Genzyme, AbbVie, and Abbott Labs, encompassing expertise in strategic marketing, cross-functional leadership, and engagement with healthcare professionals. Raz Malik holds an MBA from Northwestern University's Kellogg School of Management and a B.A. in Politics and Philosophy from The Manchester Metropolitan University.